Back
Impala Platinum Holdings Ltd. Vs. MiNK Therapeutics, Inc. Industry Stock Comparison
Buy
73
IMPUY
Impala Platinum Holdings Ltd.
Last Price:
$14.42
Seasonality Move:
9.95%
Sell
32
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.51
Seasonality Move:
-18.07%
Buy
73
Impala Platinum Holdings Ltd. (IMPUY)
is a Buy
Is Impala Platinum Holdings Ltd. a Buy, Sell or Hold?
-
The current Impala Platinum Holdings Ltd. [IMPUY] share price is $14.37. The Score for IMPUY is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
IMPUY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $11.71. The Score for INKT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IMPUY Stock Price Chart
What is Impala Platinum Holdings Ltd.'s stock price today?
-
The Impala Platinum Holdings Ltd. share price today is $14.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMPUY is experiencing slight selling pressure.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $11.71Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.
IMPUY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.61 | Buy |
| Relative Strength Index (14 RSI): | 72.7 | Buy |
| Chaikin Money Flow: | -107209 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.21 - 13.25) | Buy |
| Bollinger Bands (100): | (9.85 - 12.59) | Buy |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 45.61 | Sell |
| Chaikin Money Flow: | -20975 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.89 - 12.65) | Sell |
| Bollinger Bands (100): | (12.3 - 15.28) | Sell |
IMPUY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.32 | Buy |
| 20-day SMA: | 12.52 | Buy |
| 50-day SMA: | 11.94 | Buy |
| 200-day SMA: | 9.32 | Buy |
| 8-day EMA: | 13.43 | Buy |
| 20-day EMA: | 12.75 | Buy |
| 50-day EMA: | 12.04 | Buy |
| 200-day EMA: | 9.81 | Buy |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.32 | Sell |
| 20-day SMA: | 11.56 | Buy |
| 50-day SMA: | 12.92 | Sell |
| 200-day SMA: | 11.86 | Sell |
| 8-day EMA: | 12.05 | Sell |
| 20-day EMA: | 12.05 | Sell |
| 50-day EMA: | 12.68 | Sell |
| 200-day EMA: | 12.23 | Sell |
Impala Platinum Holdings Ltd. Earnings Growth & IMPUY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
Impala Platinum Holdings Ltd. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||